ATE486076T1 - 6-CARBOXY-NORMORPHINANE DERIVATIVES, THEIR SYNTHESIS AND USE - Google Patents
6-CARBOXY-NORMORPHINANE DERIVATIVES, THEIR SYNTHESIS AND USEInfo
- Publication number
- ATE486076T1 ATE486076T1 AT07811067T AT07811067T ATE486076T1 AT E486076 T1 ATE486076 T1 AT E486076T1 AT 07811067 T AT07811067 T AT 07811067T AT 07811067 T AT07811067 T AT 07811067T AT E486076 T1 ATE486076 T1 AT E486076T1
- Authority
- AT
- Austria
- Prior art keywords
- normorphinane
- carboxy
- synthesis
- derivatives
- normorphinane derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83568706P | 2006-08-04 | 2006-08-04 | |
PCT/US2007/017365 WO2008016704A1 (en) | 2006-08-04 | 2007-08-03 | 6-carboxy-normorphinan derivatives, synthesis and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE486076T1 true ATE486076T1 (en) | 2010-11-15 |
Family
ID=38649979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07811067T ATE486076T1 (en) | 2006-08-04 | 2007-08-03 | 6-CARBOXY-NORMORPHINANE DERIVATIVES, THEIR SYNTHESIS AND USE |
Country Status (15)
Country | Link |
---|---|
US (1) | US7501434B2 (en) |
EP (1) | EP2046800B1 (en) |
JP (1) | JP2009545629A (en) |
CN (1) | CN101522684A (en) |
AR (1) | AR062211A1 (en) |
AT (1) | ATE486076T1 (en) |
AU (1) | AU2007281408A1 (en) |
BR (1) | BRPI0715342A2 (en) |
CA (1) | CA2660027A1 (en) |
CL (1) | CL2007002272A1 (en) |
DE (1) | DE602007010151D1 (en) |
MX (1) | MX2009001282A (en) |
PE (1) | PE20080537A1 (en) |
TW (1) | TW200815451A (en) |
WO (1) | WO2008016704A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030158220A1 (en) * | 1997-11-03 | 2003-08-21 | Foss Joseph F. | Use of methylnaltrexone and related compounds to treat chronic opioid use side effects |
ES2528669T3 (en) | 2003-04-08 | 2015-02-11 | Progenics Pharmaceuticals, Inc. | Pharmaceutical formulations containing methylnaltrexone |
AR057035A1 (en) | 2005-05-25 | 2007-11-14 | Progenics Pharm Inc | SYNTHESIS OF (R) -N-METHYLNTREXONE, PHARMACEUTICAL COMPOSITIONS AND USES |
AR057325A1 (en) | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | SYNTHESIS OF (S) -N-METHYLNTREXONE, PHARMACEUTICAL COMPOSITIONS AND USES |
TW200817048A (en) * | 2006-09-08 | 2008-04-16 | Wyeth Corp | Dry powder compound formulations and uses thereof |
AU2008233133B2 (en) | 2007-03-29 | 2014-03-27 | Progenics Pharmaceuticals, Inc. | Crystal forms of (R) -N-methylnaltrexone bromide and uses thereof |
EP2565195B1 (en) | 2007-03-29 | 2015-05-06 | Wyeth LLC | Peripheral opioid receptor and antagonists and uses thereof |
PE20130480A1 (en) | 2007-03-29 | 2013-05-08 | Progenics Pharm Inc | HETEROCYCLIC COMPOUNDS AS ANTAGONISTS OF THE PERIPHERAL OPIOID RECEPTOR |
AU2008349873B2 (en) | 2008-02-06 | 2014-02-13 | Progenics Pharmaceuticals, Inc. | Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone |
US8685995B2 (en) * | 2008-03-21 | 2014-04-01 | The University Of Chicago | Treatment with opioid antagonists and mTOR inhibitors |
US20110250278A1 (en) | 2008-07-01 | 2011-10-13 | University Of Chicago | Particles containing an opioid receptor antagonist and methods of use |
CA2676881C (en) | 2008-09-30 | 2017-04-25 | Wyeth | Peripheral opioid receptor antagonists and uses thereof |
US9192570B2 (en) | 2013-12-20 | 2015-11-24 | AntiOP, Inc. | Intranasal naloxone compositions and methods of making and using same |
JP6353543B2 (en) * | 2013-12-26 | 2018-07-04 | パーデュー、ファーマ、リミテッド、パートナーシップ | Ring contraction morphinan and use thereof |
CN109096190B (en) * | 2017-06-21 | 2021-07-02 | 中国医学科学院药物研究所 | Sinomenine derivative, preparation method, application and pharmaceutical composition thereof |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4176186A (en) * | 1978-07-28 | 1979-11-27 | Boehringer Ingelheim Gmbh | Quaternary derivatives of noroxymorphone which relieve intestinal immobility |
US4719215A (en) | 1986-03-07 | 1988-01-12 | University Of Chicago | Quaternary derivatives of noroxymorphone which relieve nausea and emesis |
US4861781A (en) | 1986-03-07 | 1989-08-29 | The University Of Chicago | Quaternary derivatives of noroxymorphone which relieve nausea and emesis |
US5102887A (en) | 1989-02-17 | 1992-04-07 | Arch Development Corporation | Method for reducing emesis and nausea induced by the administration of an emesis causing agent |
NZ268969A (en) * | 1993-07-23 | 1997-06-24 | Toray Industries | Morphinan derivatives and pharmaceutical compositions |
IT1269826B (en) | 1994-05-24 | 1997-04-15 | Paolo Minoia | USE OF OPTIACEAN ANTAGONISTS AND CALCIUM SALTS FOR THE PREPARATION OF MEDICATIONS FOR THE TREATMENT OF ENDORPHINE-MEDIATED PATHOLOGICAL FORMS |
US5972954A (en) | 1997-11-03 | 1999-10-26 | Arch Development Corporation | Use of methylnaltrexone and related compounds |
US6274591B1 (en) | 1997-11-03 | 2001-08-14 | Joseph F. Foss | Use of methylnaltrexone and related compounds |
US6559158B1 (en) | 1997-11-03 | 2003-05-06 | Ur Labs, Inc. | Use of methylnaltrexone and related compounds to treat chronic opioid use side affects |
DE60329520D1 (en) | 2002-11-08 | 2009-11-12 | Mallinckrodt Inc | PROCESS FOR THE PREPARATION OF QUATERNARY N-ALKYL MORPHINAN ALKALOID SALTS |
ES2528669T3 (en) | 2003-04-08 | 2015-02-11 | Progenics Pharmaceuticals, Inc. | Pharmaceutical formulations containing methylnaltrexone |
US8946262B2 (en) | 2003-12-04 | 2015-02-03 | Adolor Corporation | Methods of preventing and treating gastrointestinal dysfunction |
AR057325A1 (en) | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | SYNTHESIS OF (S) -N-METHYLNTREXONE, PHARMACEUTICAL COMPOSITIONS AND USES |
AR057035A1 (en) | 2005-05-25 | 2007-11-14 | Progenics Pharm Inc | SYNTHESIS OF (R) -N-METHYLNTREXONE, PHARMACEUTICAL COMPOSITIONS AND USES |
TWI489984B (en) | 2006-08-04 | 2015-07-01 | Wyeth Corp | Formulations for parenteral delivery of compounds and uses thereof |
TW200817048A (en) | 2006-09-08 | 2008-04-16 | Wyeth Corp | Dry powder compound formulations and uses thereof |
WO2008064150A1 (en) | 2006-11-22 | 2008-05-29 | Progenics Pharmaceuticals, Inc. | Processes for synthesizing quaternary 4,5-epoxy-morphinan analogs and isolating their n-stereoisomers |
BRPI0719305A2 (en) | 2006-11-22 | 2014-02-04 | Progenics Pharm Inc | (R) - 7,8-SATURATED-4,5-EPOXY-MORFINAN ANALOG STEREOISOMERS |
AU2007329590A1 (en) | 2006-11-22 | 2008-06-12 | Progenics Pharmaceuticals, Inc. | N-oxides of 4,5-epoxy-morphinanium analogs |
EP2565195B1 (en) | 2007-03-29 | 2015-05-06 | Wyeth LLC | Peripheral opioid receptor and antagonists and uses thereof |
PE20130480A1 (en) | 2007-03-29 | 2013-05-08 | Progenics Pharm Inc | HETEROCYCLIC COMPOUNDS AS ANTAGONISTS OF THE PERIPHERAL OPIOID RECEPTOR |
-
2007
- 2007-07-30 TW TW096127797A patent/TW200815451A/en unknown
- 2007-08-02 PE PE2007001008A patent/PE20080537A1/en not_active Application Discontinuation
- 2007-08-03 CN CNA2007800370327A patent/CN101522684A/en active Pending
- 2007-08-03 MX MX2009001282A patent/MX2009001282A/en not_active Application Discontinuation
- 2007-08-03 DE DE602007010151T patent/DE602007010151D1/en active Active
- 2007-08-03 CA CA002660027A patent/CA2660027A1/en not_active Abandoned
- 2007-08-03 JP JP2009523790A patent/JP2009545629A/en active Pending
- 2007-08-03 WO PCT/US2007/017365 patent/WO2008016704A1/en active Application Filing
- 2007-08-03 CL CL200702272A patent/CL2007002272A1/en unknown
- 2007-08-03 AU AU2007281408A patent/AU2007281408A1/en not_active Abandoned
- 2007-08-03 AT AT07811067T patent/ATE486076T1/en not_active IP Right Cessation
- 2007-08-03 US US11/888,955 patent/US7501434B2/en not_active Expired - Fee Related
- 2007-08-03 BR BRPI0715342 patent/BRPI0715342A2/en not_active Application Discontinuation
- 2007-08-03 EP EP07811067A patent/EP2046800B1/en not_active Not-in-force
- 2007-08-03 AR ARP070103441A patent/AR062211A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2007281408A1 (en) | 2008-02-07 |
JP2009545629A (en) | 2009-12-24 |
PE20080537A1 (en) | 2008-06-23 |
EP2046800B1 (en) | 2010-10-27 |
MX2009001282A (en) | 2009-02-11 |
CN101522684A (en) | 2009-09-02 |
CA2660027A1 (en) | 2008-02-07 |
US20080064744A1 (en) | 2008-03-13 |
CL2007002272A1 (en) | 2008-04-18 |
WO2008016704A1 (en) | 2008-02-07 |
TW200815451A (en) | 2008-04-01 |
EP2046800A1 (en) | 2009-04-15 |
BRPI0715342A2 (en) | 2015-03-24 |
AR062211A1 (en) | 2008-10-22 |
DE602007010151D1 (en) | 2010-12-09 |
US7501434B2 (en) | 2009-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE486076T1 (en) | 6-CARBOXY-NORMORPHINANE DERIVATIVES, THEIR SYNTHESIS AND USE | |
ATE540952T1 (en) | PYRROLOÄ2,3-DÜPYRIMIDINE DERIVATIVES, THEIR INTERMEDIATE PRODUCTS AND SYNTHESIS | |
ATE543808T1 (en) | 5,6-RING-ANNELATED INDOLE DERIVATIVES AND USE THEREOF | |
ATE467633T1 (en) | 2-ARYL-6-PHENYLIMIDAZOÄ1,2-AÜPYRIDINE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE | |
ATE531712T1 (en) | SUBSTITUTED ARYLOXAZOLES AND THEIR USE | |
ATE548355T1 (en) | 4-(4-CYANO-2-THIOARYL)-DIHYDROPYRIMIDINONE AND THEIR USE | |
BRPI0818373A2 (en) | pelicetal compounds, synthesis and applications | |
DK1868967T3 (en) | HYDROCARBON SYNTHESIS | |
ATE517886T1 (en) | PYRAZOLE DERIVATIVES | |
ATE487691T1 (en) | ACETYLENE DERIVATIVES | |
ATE413389T1 (en) | QUINAZOLINE DERIVATIVES | |
ATE487718T1 (en) | SUBSTITUTED BIZYCLIC PYRIMIDONE DERIVATIVES | |
ATE428710T1 (en) | SUBSTITUTED PHENYLAMINOTHIAZOLES AND THEIR USE | |
ATE547002T1 (en) | PESTICIDES AND THEIR USE | |
NL2000527A1 (en) | Dibenzylamine compounds and derivatives. | |
DE602006010581D1 (en) | 4-PHENYL-6-SUBSTITUTED PYRIMIDIN-2-CARBONITRILE DERIVATIVES | |
ATE544752T1 (en) | ARYLOXYACETAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES | |
ATE485294T1 (en) | AZAINDOL-2-CARBOXAMIDE DERIVATIVES | |
ATE527255T1 (en) | ARYL-ISOXAZOLE-4-YL-IMIDAZOLE DERIVATIVES | |
DK1971588T3 (en) | Tiglien-3-one derivatives | |
ATE472549T1 (en) | OCTAHYDROPYRROLOÄ3,4-CUPYRROL DERIVATIVES AND THEIR USE AS ANTIVIRAL AGENTS | |
ATE451923T1 (en) | N-(ARYLALKYL)-1H-PYRROLOPYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND USE | |
ATE513817T1 (en) | PYRIMIDINE DERIVATIVES AND THEIR USE AS PESTICIDES | |
DE602006000612D1 (en) | Reversible orthosis | |
HK1136159A1 (en) | Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |